Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer

Fig. 1

Kaplan-Meier survival plots for overall survival according to digitalMLPA BRCAness status and stratified for treatment in the Dutch high-dose study. Survival is subsequently shown all patients (a), for non-BRCA-like patients (b), BRCA1-like patients (c), BRCA2-like patients (d), BRCA-like patients (e), ER+ non-BRCA-like patients (f), and ER+ BRCA-like patients (g). p values have been obtained by log-rank test

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us